Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix Medical is a leading medical device company that is poised for strong growth potential, driven by its innovative spine and limb reconstruction solutions. Despite potential reimbursement headwinds, the company's bone growth stimulator business is expected to generate significant revenue in the future, and overall revenue is projected to continue growing through 2026. Additionally, the company's balance sheet position is strong, with high cash and low debt levels. They have also shown strong profitability, with consistent positive free cash flow and strong adjusted EBITDA margins. While there may be near-term challenges, Orthofix's long-term outlook remains bright, supported by its ongoing streamlining activities and strategic vision for growth.

Orthofix Medical is facing challenges in its global spine and global orthopedics segments, with a reduction in its FY/26 revenue and adjusted EBITDA guidance. This is driven by lower-than-expected revenue from spinal implants, biologics, and enabling technologies, as well as a lack of positive free cash flow in the upcoming fiscal year. Additionally, the company's longer-term financial targets have been pushed back to FY/28 and there are risks that the target price may not be achieved due to potential failure to meet revenue and earnings estimates.